Y-mAbs Therapeutics, Inc. Current Liabilities
Y-mAbs Therapeutics, Inc. had Current Liabilities of $22.95 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-08-08
- 2025-06-30: Liabilities, Current $22.95M.
- 2025-03-31: Liabilities, Current $18.96M.
- 2024-12-31: Liabilities, Current $23.70M.
- 2024-09-30: Liabilities, Current $25.29M.
| Period end | Liabilities, Current |
|---|---|
| 2025-06-30 | $22.95M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $18.96M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $23.70M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $25.29M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $43.47M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $17.61M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $20.13M 10-K · filed 2025-03-04 |
| 2023-09-30 | $21.81M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $24.23M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $25.92M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $28.28M 10-K · filed 2024-02-29 |
| 2022-09-30 | $32.02M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $29.45M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $29.04M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $27.88M 10-K · filed 2023-03-30 |
| 2021-09-30 | $25.36M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $20.99M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $17.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $19.54M 10-K · filed 2022-03-01 |
| 2020-09-30 | $19.78M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $15.71M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.84M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $13.59M 10-K · filed 2021-03-01 |
| 2019-09-30 | $13.99M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $13.63M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $10.30M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $9.12M 10-K · filed 2020-03-12 |
| 2018-09-30 | $9.32M 10-Q · filed 2018-11-13 |
| 2017-12-31 | $7.92M 10-K · filed 2019-03-22 |